$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Analysis on whether Roprostim (Huierning) needs to be taken continuously for a long time
2026-02-01 22:25:32
Check Details
How long does it take to take Midostaurin to achieve the desired therapeutic effect?
2026-02-01 22:25:32
Check Details
What dose of cabergoline is needed to be safe and effective when breastfeeding?
2026-02-01 22:25:32
Check Details
The current market price of Momelotinib and reference information from different channels
2026-02-01 22:25:32
Check Details
Is Biken Pronol Tablets (Bituvi) most effective when taken before or after meals?
2026-02-01 22:25:32
Check Details
Deuterated colexitinib (decavatinib) medical insurance reimbursement policy and precautions for self-pay patients
2026-02-01 22:25:32
Check Details
The latest market price of Apremilast, how much is a box and where to buy it
2026-02-01 22:25:32
Check Details
How to use Valganciclovir to prevent infection in organ transplant patients
2026-02-01 22:25:32
Check Details
Detailed explanation of the efficacy and role of Mecobalamin and analysis of its clinical application scope
2026-02-01 22:25:32
Check Details
Cobimetinib’s latest mechanism of action analysis and drug market price reference
2026-02-01 22:25:32
Check Details
The complete version of the official instructions for macitentan (Aoposu) and the interpretation of the latest medication guide
2026-02-01 22:25:32
Check Details
Complete instructions for Tilorisen (Harcos) and interpretation of the latest indications and medication guidelines
2026-02-01 22:25:32
Check Details
1
2
...
2239
2240
2241
2242
2243
2244
2245
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma